Search

everythinglearnresearchcommunity

for

Search:↓

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Integrin-linked kinase is crucial for normal skin healing.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Phospholipids from pig lungs can significantly promote hair growth.

Sinapic acid may help hair growth by activating a specific cell pathway.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Nilotinib can cause skin issues like red bumps and hair loss.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Compound 4 is a promising treatment for hair loss with low toxicity.